Dermatologic Manifestations of Homocystinuria Differential Diagnoses

  • Author: Janette Baloghova, MD, PhD; Chief Editor: Dirk M Elston, MD   more...
 
Updated: Oct 11, 2011
 
 

Differential Diagnoses

Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Janette Baloghova, MD, PhD  Lecturer, Medical Faculty, University of PJ Safarik; Dermatovenerologist, Faculty Hospital of L Pasteur, Slovak Republic

Disclosure: Nothing to disclose.

Coauthor(s)

Robert A Schwartz, MD, MPH  Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi

Disclosure: Nothing to disclose.

Zuzana Baranova, MD, PhD  Senior Lecturer, Department of Dermatology, University of PJ Safarik at Kosice, Slovak Republic

Disclosure: Nothing to disclose.

Specialty Editor Board

Jacek C Szepietowski, MD, PhD  Professor, Vice-Head, Department of Dermatology, Venereology and Allergology, Wroclaw Medical University; Director of the Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Poland

Disclosure: Stiefel GSK Company Salary Employment; Orfagen Consulting fee Consulting; Maruho Consulting fee Consulting; Astellas Consulting fee Consulting; Abbott Consulting fee Consulting; Leo Pharma Consulting fee Consulting

David F Butler, MD  Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Warren R Heymann, MD  Head, Division of Dermatology, Professor, Department of Internal Medicine, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Warren R Heymann, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Catherine M Quirk, MD  Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania

Catherine M Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD  Director, Ackerman Academy of Dermatopathology, New York

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

References

  1. Mudd SH, Skovby F, Levy HL, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. Jan 1985;37(1):1-31. [Medline].

  2. Finkelstein JD. Inborn errors of sulfur-containing amino acid metabolism. J Nutr. Jun 2006;136(6 Suppl):1750S-1754S. [Medline].

  3. Vyletal P, Sokolova J, Cooper DN, et al. Diversity of cystathionine beta-synthase haplotypes bearing the most common homocystinuria mutation c.833T>C: a possible role for gene conversion. Hum Mutat. Mar 2007;28(3):255-64. [Medline].

  4. Augoustides-Savvopoulou P, Luka Z, Karyda S, et al. Glycine N -methyltransferase deficiency: a new patient with a novel mutation. J Inherit Metab Dis. 2003;26(8):745-59. [Medline].

  5. Orendae M, Pronicka E, Kubalska J, et al. Identification and functional analysis of two novel mutations in the CBS gene in Polish patients with homocystinuria. Hum Mutat. Jun 2004;23(6):631. [Medline].

  6. Whiteman P, Hutchinson S, Handford PA. Fibrillin-1 misfolding and disease. Antioxid Redox Signal. Mar-Apr 2006;8(3-4):338-46. [Medline].

  7. Morel CF, Lerner-Ellis JP, Rosenblatt DS. Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. Mol Genet Metab. Aug 2006;88(4):315-21. [Medline].

  8. Baumgartner ER, Wick H, Maurer R, et al. Congenital defect in intracellular cobalamin metabolism resulting in homocysteinuria and methylmalonic aciduria. I. Case report and histopathology. Helv Paediatr Acta. 1979;34(5):465-82. [Medline].

  9. Zavadakova P, Fowler B, Zeman J, et al. CblE type of homocystinuria due to methionine synthase reductase deficiency: clinical and molecular studies and prenatal diagnosis in two families. J Inherit Metab Dis. Oct 2002;25(6):461-76. [Medline].

  10. Coelho D, Suormala T, Stucki M, et al. Gene identification for the cblD defect of vitamin B12 metabolism. N Engl J Med. Apr 3 2008;358(14):1454-64. [Medline].

  11. Elshorbagy AK, Nurk E, Gjesdal CG, et al. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism?. Am J Clin Nutr. Sep 2008;88(3):738-46. [Medline].

  12. Rummel T, Suormala T, Haberle J, et al. Intermediate hyperhomocysteinaemia and compound heterozygosity for the common variant c.677C>T and a MTHFR gene mutation. J Inherit Metab Dis. Jun 2007;30(3):401. [Medline].

  13. Bishop L, Kanoff R, Charnas L, Krenzel C, Berry SA, Schimmenti LA. Severe methylenetetrahydrofolate reductase (MTHFR) deficiency: a case report of nonclassical homocystinuria. J Child Neurol. Jul 2008;23(7):823-8. [Medline].

  14. Jakubowski H, Boers GH, Strauss KA. Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans. FASEB J. Dec 2008;22(12):4071-6. [Medline].

  15. Miroslav Janošík, Jitka Sokolová, Bohumila Janošíková, Jakub Krijt, Veronika Klatovská, Viktor Kožich. Birth Prevalence of Homocystinuria in Central Europe: Frequency and Pathogenicity of Mutation c.1105C>T (p.R369C) in the Cystathionine Beta-Synthase Gene. J Pediatr. March 2009;154(3):431–437.

  16. Alehan F, Saygi S, Gedik S, Kayahan Ulu EM. Stroke in early childhood due to homocystinuria. Pediatr Neurol. Oct 2010;43(4):294-6. [Medline].

  17. Shaker OG, El-Tahlawi SM. Is there a relationship between homocysteine and vitiligo? A pilot study. Br J Dermatol. Sep 2008;159(3):720-4. [Medline].

  18. Tallur KK, Johnson DA, Kirk JM, et al. Folate-induced reversal of leukoencephalopathy and intellectual decline in methylene-tetrahydrofolate reductase deficiency: variable response in siblings. Dev Med Child Neurol. Jan 2005;47(1):53-6. [Medline].

  19. Sato Y, Iwamoto J, Kanoko T, Satoh K. Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease. Am J Med. Nov 2005;118(11):1250-5. [Medline].

  20. Gerth C, Morel CF, Feigenbaum A, Levin AV. Ocular phenotype in patients with methylmalonic aciduria and homocystinuria, cobalamin C type. J AAPOS. Dec 2008;12(6):591-6. [Medline].

  21. Gaillard MC, Matthieu JM, Borruat FX. Retinal dysfunction in combined methylmalonic aciduria and homocystinuria (Cblc) disease: a spectrum of disorders. Klin Monatsbl Augenheilkd. May 2008;225(5):491-4. [Medline].

  22. D'Alessandro G, Tagariello T, Piana G. Oral and craniofacial findings in a patient with methylmalonic aciduria and homocystinuria: review and a case report. Minerva Stomatol. Mar 2010;59(3):129-37. [Medline].

  23. James SJ, Cutler P, Melnyk S, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. Dec 2004;80(6):1611-7. [Medline].

  24. Ichinohe A, Kanaumi T, Takashima S, Enokido Y, Nagai Y, Kimura H. Cystathionine beta-synthase is enriched in the brains of Down's patients. Biochem Biophys Res Commun. Dec 23 2005;338(3):1547-50. [Medline].

  25. Wilcken DE, Wang J, Sim AS, et al. Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function. J Inherit Metab Dis. Feb 2006;29(1):30-7. [Medline].

  26. Snyderman SE. Liver failure and neurologic disease in a patient with homocystinuria. Mol Genet Metab. Mar 2006;87(3):210-2. [Medline].

  27. Diana Muacevic-Katanec, Tihomir Kekez, Ksenija Fumic, Ivo Baric, Marijan Merkler,Jasminka Jakic-Razumovic, et al. Spontaneous Perforation of the Small Intestine, a Novel Manifestation of Classical Homocystinuria in an Adult with New Cystathionine ß-synthetaseGene Mutations. Coll. Antropol. 2011, Mar;35:181-185. [Medline].

  28. Fowler B, Schutgens RB, Rosenblatt DS, et al. Folate-responsive homocystinuria and megaloblastic anaemia in a female patient with functional methionine synthase deficiency (cblE disease). J Inherit Metab Dis. Nov 1997;20(6):731-41. [Medline].

  29. Febriani AD, Sakamoto A, Ono H, et al. Determination of total homocysteine in dried blood spots using high performance liquid chromatography for homocystinuria newborn screening. Pediatr Int. Feb 2004;46(1):5-9. [Medline].

  30. Refsum H, Fredriksen A, Meyer K, et al. Birth prevalence of homocystinuria. J Pediatr. Jun 2004;144(6):830-2. [Medline].

  31. Navratil T, Petr M, Senholdova Z, et al. Diagnostic significance of urinary thiodiglycolic acid as a possible tool for studying the role of vitamins B12 and folates in the metabolism of thiolic substances. Physiol Res. Feb 23 2006;[Medline].

  32. Sen S, Yu J, Yamanishi M, Schellhorn D, Banerjee R. Mapping peptides correlated with transmission of intrasteric inhibition and allosteric activation in human cystathionine beta-synthase. Biochemistry. Nov 1 2005;44(43):14210-6. [Medline].

  33. Jakub Krijt, Jana Kopecká, Aleš Hnízda, Stuart Moat, Leo A. J. Kluijtmans, Philip Mayne, et al. Determination of cystathionine beta-synthase activity in human plasma by LC-MS/MS: potential use in diagnosis of CBS deficiency. J Inherit Metab Dis. February 2011;34(1):49–55. [Medline].

  34. Scherer EB, Stefanello FM, Mattos C, Netto CA, Wyse AT. Homocysteine reduces cholinesterase activity in rat and human serum. Int J Dev Neurosci. Jun 2007;25(4):201-5. [Medline].

  35. Debray FG, Boulanger Y, Khiat A, et al. Reduced brain choline in homocystinuria due to remethylation defects. Neurology. Jul 1 2008;71(1):44-9. [Medline].

  36. Longo D, Fariello G, Dionisi-Vici C, et al. MRI and 1H-MRS findings in early-onset cobalamin C/D defect. Neuropediatrics. Dec 2005;36(6):366-72. [Medline].

  37. Gahl WA, Bernardini I, Chen S, et al. The effect of oral betaine on vertebral body bone density in pyridoxine-non-responsive homocystinuria. J Inherit Metab Dis. 1988;11(3):291-8. [Medline].

  38. Lawson-Yuen A, Levy HL. The use of betaine in the treatment of elevated homocysteine. Mol Genet Metab. Jul 2006;88(3):201-7. [Medline].

  39. Singh RH, Kruger WD, Wang L, et al. Cystathionine beta-synthase deficiency: effects of betaine supplementation after methionine restriction in B6-nonresponsive homocystinuria. Genet Med. Mar-Apr 2004;6(2):90-5. [Medline].

  40. Sakamoto A, Sakura N. Limited effectiveness of betaine therapy for cystathionine beta synthase deficiency. Pediatr Int. Jun 2003;45(3):333-8. [Medline].

  41. Yaghmai R, Kashani AH, Geraghty MT, et al. Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine beta-synthase (CBS) deficiency. Am J Med Genet. Feb 15 2002;108(1):57-63. [Medline].

  42. Tada H, Takanashi J, Barkovich AJ, et al. Reversible white matter lesion in methionine adenosyltransferase I/III deficiency. AJNR Am J Neuroradiol. Nov-Dec 2004;25(10):1843-5. [Medline].

  43. Alan L, Miller ND, Gregory S. Methionine and homocysteine metabolism and the nutritional prevention of certain birth defects and complications of pregnancy. Alt Med Rev. 1996;1:220-35.

  44. Confalonieri M, Parigi P, Scartabellati A, et al. Heterozygosity for homocysteinuria: a detectable and reversible risk factor for pulmonary thromboembolism. Monaldi Arch Chest Dis. Apr 1995;50(2):114-5. [Medline].

  45. Cruysberg JR, Boers GH, Trijbels JM, Deutman AF. Delay in diagnosis of homocystinuria: retrospective study of consecutive patients. BMJ. Oct 26 1996;313(7064):1037-40. [Medline].

  46. Kim SZ, Santamaria E, Jeong TE, et al. Methionine adenosyltransferase I/III deficiency: two Korean compound heterozygous siblings with a novel mutation. J Inherit Metab Dis. Dec 2002;25(8):661-71. [Medline].

  47. Kozich Viktor, Sokolova Jitka, Klatovska Veronika, Krijt Jakub, Janosik Miroslav, Jelinek Karel, et al. Cystathionine b-Synthase Mutations: Effect of Mutation Topology on Folding and Activity. HUMAN MUTATION. 2010, No. 7;Vol. 31:809–819.

  48. Kraus JP. Komrower Lecture. Molecular basis of phenotype expression in homocystinuria. J Inherit Metab Dis. 1994;17(4):383-90. [Medline].

  49. Moat SJ, Bao L, Fowler B, et al. The molecular basis of cystathionine beta-synthase (CBS) deficiency in UK and US patients with homocystinuria. Hum Mutat. Feb 2004;23(2):206. [Medline].

  50. Nugent A, Hadden DR, Carson NA. Long-term survival of homocystinuria: the first case. Lancet. Aug 22 1998;352(9128):624-5. [Medline].

  51. Orendac M, Zeman J, Stabler SP, et al. Homocystinuria due to cystathionine beta-synthase deficiency: novel biochemical findings and treatment efficacy. J Inherit Metab Dis. 2003;26(8):761-73. [Medline].

  52. Scriver CR, Beaudet AL, Sly WS. The Metabolic and Molecular Bases of Inherited Diseases. 7th ed. New York, NY: McGraw-Hill; 1995.

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.